A detailed history of Capital Analysts, LLC transactions in Organon & Co. stock. As of the latest transaction made, Capital Analysts, LLC holds 140 shares of OGN stock, worth $2,067. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140
Previous 164 14.63%
Holding current value
$2,067
Previous $3,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $447 - $552
-24 Reduced 14.63%
140 $3,000
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $436 - $549
25 Added 17.99%
164 $3,000
Q1 2024

May 14, 2024

SELL
$13.78 - $18.8 $3,472 - $4,737
-252 Reduced 64.45%
139 $3,000
Q4 2023

Jan 30, 2024

SELL
$10.95 - $17.32 $9,844 - $15,570
-899 Reduced 69.69%
391 $5,000
Q3 2023

Nov 13, 2023

BUY
$16.59 - $23.77 $364 - $522
22 Added 1.74%
1,290 $23,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $1,888 - $2,413
98 Added 8.38%
1,268 $26,000
Q1 2023

May 05, 2023

SELL
$21.42 - $32.08 $171 - $256
-8 Reduced 0.68%
1,170 $28,000
Q4 2022

Feb 08, 2023

SELL
$23.31 - $28.61 $396 - $486
-17 Reduced 1.42%
1,178 $33,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $163 - $239
-7 Reduced 0.58%
1,195 $28,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $89,059 - $109,425
-2,813 Reduced 70.06%
1,202 $41,000
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $26,582 - $34,361
-873 Reduced 17.86%
4,015 $140,000
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $12,070 - $15,631
-421 Reduced 7.93%
4,888 $149,000
Q3 2021

Nov 04, 2021

SELL
$28.63 - $35.64 $11,280 - $14,042
-394 Reduced 6.91%
5,309 $174,000
Q2 2021

Nov 15, 2021

SELL
$28.45 - $38.0 $9,673 - $12,920
-340 Reduced 5.63%
5,703 $173,000
Q2 2021

Aug 05, 2021

BUY
$28.45 - $38.0 $171,923 - $229,634
6,043 New
6,043 $183,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.